338 related articles for article (PubMed ID: 18393299)
21. Quantification of gabapentin polymorphs in gabapentin/excipient mixtures using solid state
Tinmanee R; Larsen SC; Morris KR; Kirsch LE
J Pharm Biomed Anal; 2017 Nov; 146():29-36. PubMed ID: 28843174
[TBL] [Abstract][Full Text] [Related]
22. Four new polymorphic forms of suplatast tosilate.
Nagai K; Ushio T; Miura H; Nakamura T; Moribe K; Yamamoto K
Int J Pharm; 2014 Jan; 460(1-2):83-91. PubMed ID: 24211359
[TBL] [Abstract][Full Text] [Related]
23. The determination of crystal structures of active pharmaceutical ingredients from X-ray powder diffraction data: a brief, practical introduction, with fexofenadine hydrochloride as example.
Brüning J; Schmidt MU
J Pharm Pharmacol; 2015 Jun; 67(6):773-81. PubMed ID: 25677117
[TBL] [Abstract][Full Text] [Related]
24. Novel polymorph of ambrisentan: Characterization and stability.
Haneef J; Chadha R; Gupta V; Mandal SK
J Pharm Biomed Anal; 2018 May; 153():102-109. PubMed ID: 29475138
[TBL] [Abstract][Full Text] [Related]
25. Structural analysis of polymorphism and solvation in tranilast.
Vogt FG; Cohen DE; Bowman JD; Spoors GP; Zuber GE; Trescher GA; Dell'orco PC; Katrincic LM; Debrosse CW; Curtis Haltiwanger R
J Pharm Sci; 2005 Mar; 94(3):651-65. PubMed ID: 15666296
[TBL] [Abstract][Full Text] [Related]
26. Structural characterization of three crystalline modifications of telmisartan by single crystal and high-resolution X-ray powder diffraction.
Dinnebier RE; Sieger P; Nar H; Shankland K; David WI
J Pharm Sci; 2000 Nov; 89(11):1465-79. PubMed ID: 11015691
[TBL] [Abstract][Full Text] [Related]
27. Quantitative and molecular analysis of buspirone hydrochloride polymorphs.
Sheikhzadeh M; Rohani S; Jutan A; Manifar T
J Pharm Sci; 2007 Mar; 96(3):569-83. PubMed ID: 17094124
[TBL] [Abstract][Full Text] [Related]
28. Challenging identification of polymorphic mixture: Polymorphs I, II and III in olanzapine raw materials.
Testa CG; Prado LD; Costa RN; Costa ML; Linck YG; Monti GA; Cuffini SL; Rocha HVA
Int J Pharm; 2019 Feb; 556():125-135. PubMed ID: 30543891
[TBL] [Abstract][Full Text] [Related]
29. Polymorphism of a novel sodium ion channel blocker.
Cheung EY; Harris KD; Johnston RL; Hadden KL; Zakrzewski M
J Pharm Sci; 2003 Oct; 92(10):2017-26. PubMed ID: 14502541
[TBL] [Abstract][Full Text] [Related]
30. Structure determination of forms I and II of phenobarbital from X-ray powder diffraction.
Platteau C; Lefebvre J; Hemon S; Baehtz C; Danede F; Prevost D
Acta Crystallogr B; 2005 Feb; 61(Pt 1):80-8. PubMed ID: 15659860
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, Characterization, and Crystal Chemistry of Tasimelteon, a Melatonin Agonist, in Its Anhydrous and Hemihydrate Forms.
Ventimiglia G; Bellomi S; Barreca G; Giovannelli L; Masciocchi N
J Pharm Sci; 2018 Feb; 107(2):543-549. PubMed ID: 28947337
[TBL] [Abstract][Full Text] [Related]
32. Structure determination from conventional powder diffraction data: application to hydrates, hydrochloride salts, and metastable polymorphs.
Stephenson GA
J Pharm Sci; 2000 Jul; 89(7):958-66. PubMed ID: 10861598
[TBL] [Abstract][Full Text] [Related]
33. Structural and thermal characterization of zolpidem hemitartrate hemihydrate (Form E) and its decomposition products by laboratory X-ray powder diffraction.
Halasz I; Dinnebier RE
J Pharm Sci; 2010 Feb; 99(2):871-8. PubMed ID: 19697390
[TBL] [Abstract][Full Text] [Related]
34. Clarithromycin form I determined by synchrotron X-ray powder diffraction.
Noguchi S; Miura K; Fujiki S; Iwao Y; Itai S
Acta Crystallogr C; 2012 Feb; 68(Pt 2):o41-4. PubMed ID: 22307251
[TBL] [Abstract][Full Text] [Related]
35. alpha- and beta-FOX-7, polymorphs of a high energy density material, studied by X-ray single crystal and powder investigations in the temperature range from 200 to 423 K.
Evers J; Klapötke TM; Mayer P; Oehlinger G; Welch J
Inorg Chem; 2006 Jun; 45(13):4996-5007. PubMed ID: 16780321
[TBL] [Abstract][Full Text] [Related]
36. Lisinopril dihydrate: single-crystal x-ray structure and physicochemical characterization of derived solid forms.
Sorrenti M; Catenacci L; Cruickshank DL; Caira MR
J Pharm Sci; 2013 Oct; 102(10):3596-603. PubMed ID: 23873413
[TBL] [Abstract][Full Text] [Related]
37. Polymorphism of Alprazolam (Xanax): a review of its crystalline phases and identification, crystallographic characterization, and crystal structure of a new polymorph (form III).
de Armas HN; Peeters OM; Van den Mooter G; Blaton N
J Pharm Sci; 2007 May; 96(5):1114-30. PubMed ID: 17455340
[TBL] [Abstract][Full Text] [Related]
38. [Preparation and characterization of Forms A and B of benazepril hydrochloride].
Fang H; Hu XR; Gu JM; Chen GX; Feng JY; Tang GP
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 41(6):639-46. PubMed ID: 23239655
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive spectroscopic characterization of finasteride polymorphic forms. Does the form X exist?
Frelek J; Górecki M; Dziedzic A; Jabłońska E; Kamieński B; Wojcieszczyk RK; Luboradzki R; Szczepek WJ
J Pharm Sci; 2015 May; 104(5):1650-7. PubMed ID: 25648836
[TBL] [Abstract][Full Text] [Related]
40. Polymorphism of linezolid: a combined single-crystal, powder diffraction and NMR study.
Maccaroni E; Alberti E; Malpezzi L; Masciocchi N; Vladiskovic C
Int J Pharm; 2008 Mar; 351(1-2):144-51. PubMed ID: 17977677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
